SHAPE-ENDO
Not yet recruiting
82 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
THRIVE
Recruiting
1,000 enrolled
PARIB-OLD-PRO²
Recruiting
50 enrolled
BASECAMP-1
Recruiting
200 enrolled
NCG-Compliance
Recruiting
618 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CHARM1
Active not recruiting
1,416 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
EPICOL-R
Recruiting
120 enrolled
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Completed
40 enrolled
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
Terminated
22 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Completed
22 enrolled
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Recruiting
1,200 enrolled
Assessment of Paclitaxel-Induced Neuropathy
Active not recruiting
43 enrolled
Early Ageing During Therapy in AYA Cancer Patients
Recruiting
120 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
SURVIMON
Active not recruiting
100,000 enrolled
Estrogen, Diet, Genetics and Endometrial Cancer
Active not recruiting
1,315 enrolled
LARENA
Completed
351 enrolled
TRUTH
Recruiting
250 enrolled
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
Recruiting
1,000 enrolled
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Recruiting
15,000 enrolled
Optimization of MRI for Radiation Therapy
Completed
250 enrolled
3D-PEDSURG
Recruiting
60 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
RADIANT
Completed
16 enrolled
CONTEST
Completed
90 enrolled
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Completed
174 enrolled
CER
Recruiting
15,000 enrolled
Post Market Clinical Follow-up Study Venezia
Completed
41 enrolled
OVAmiARN
Recruiting
250 enrolled
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
Completed
26 enrolled
ASAP
Recruiting
25,000 enrolled
HALO
Completed
605 enrolled
Artificial Intelligence Enables Precision Diagnosis of Cervical Cytology Grades and Cervical Cancer
Completed
16,164 enrolled
Malignant Pediatric Pelvic Tumors: A Retrospective Study
Unknown
90 enrolled
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Completed
1,031 enrolled
ELISA
Unknown
320 enrolled
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
Completed
20 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
EU-VALHUDES
Completed
600 enrolled
PASSION
Unknown
1,800 enrolled
PHRC2003
Completed
364 enrolled 4 charts
Urine-hrHPV
Unknown
1,000 enrolled
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
Unknown
3,000 enrolled
PIONEER
Unknown
1,000 enrolled
Continuation of Follow-up of DES-Exposed Cohorts
Completed
10,805 enrolled